Bernie Sanders Introduces Drug Importation Bill
Led by Senator Bernie Sanders, I-Vermont, Democrats introduced a new bill that would allow drugs from Canada to be imported to the United States. The Washington Post reported that the new bill would put increased pressure on pharmaceutical companies to bring down the price of drugs. During his campaign, President Donald Trump had expressed support for such an idea. Opponents of the law argue that it could result in patient harm if unsafe drugs make it into the United States.
Paul Ryan Has His Eye on Medicare Reform
While Trump promised not to make any cuts to Medicare, House Speaker Paul Ryan, R-Wisconsin, is singing a different tune. Ryan believes that the issue of Medicare is an open question and that the president only wants to keep benefits unchanged for people in or near retirement, according to CNN. Ryan believes that Medicare needs to be reformed in order to keep the program solvent.
Trump Derides FDA’s Process
During his joint address to Congress, the president called the FDA’s current drug approval process “slow and burdensome.” (To see more of his comments from the address, read our article.) STAT reported that Trump called on the FDA to speed up the approval of drugs for life-threatening diseases, and in the past he has called for eliminating regulations. As of yet, Trump has not nominated a commissioner to head the FDA.
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More